The unprecedented and deadly cruise ship hantavirus outbreak, explained

“This is not COVID,” and other reasons why risk to the public is currently low.

There Is No ‘Hard Problem Of Consciousness’

Consciousness is not separate from the physical world — our “soul” is of the same nature as our body and any other phenomenon of the world.

SPONSORED How health systems navigate patient data with Claude

Health systems are sitting on massive amounts of clinical data, but turning that data into timely patient care isn't always easy.

Announcing Premium Health Sources

Today we are launching Premium Health Sources. This continues our investment in premium sources and will allow Perplexity to draw from the same clinical references used by physicians and researchers.

In Harvard study, AI offered more accurate diagnoses than emergency room doctors

A new study examines how large language models perform in a variety of medical contexts, including real emergency room cases — where at least one model seemed to be more accurate than human doctors.

ByteDance's Anew Labs Presents First AI-Designed Therapy as TikTok Parent Enters Drug Discovery Race

ByteDance’s drug discovery unit Anew Labs presented its first AI-designed therapy at a major immunology conference in Boston, showing a generative-AI-designed small molecule targeting IL-17, a protein-protein interaction long considered undruggable.

Man dies covered in necrotic lesions after amoebas eat him alive

Doctors suspect three factors, each unremarkable on its own, contributed to his fate.

FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.

Maintaining momentum and morale during the long road to FDA approval, with Robhy Bustami, BioticsAI

Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building [...]

AI co-clinician: researching the path toward AI-augmented care

Google DeepMind is researching the path toward an AI co-clinician that could work under physician authority to assist doctors and patients, enabling new models for AI-augmented care.

Flesh-eating bacteria devour man's arm and leg in just three days

When doctors saw him, his limbs were discolored and crackling.

Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI

Summary: Stanford professor James Zou is reportedly raising approximately $100 million at a valuation targeting $1 billion for a startup called Human Intelligence that applies AI to research on the human body, according to Bloomberg. Zou’s research includes an FDA-cleared cardiac AI (EchoNet), a Nature-published Virtual Lab that designed novel nanobodies, and a Virtual Biotech multi-agent framework that annotated 56,000 clinical trials. The deal specifics are single-source, but the researcher’s credentials are among the strongest in AI-biology, and the funding environment, $11 billion into AI drug discovery in Q1 2026 alone, is historically accommodating.